EC Number   |
Activating Compound |
Reference |
|---|
   2.7.10.2 | CXCL12 |
- |
738741 |
| 2.7.10.2 | cytokine receptors |
- |
672954 |
| 2.7.10.2 | Epidermal growth factor |
- |
690368 |
| 2.7.10.2 | epithelial growth factor receptor |
- |
694492 |
| 2.7.10.2 | insulin-like growth factor 1 receptor |
- |
694492 |
| 2.7.10.2 | lipopolysaccharide |
- |
691455 |
| 2.7.10.2 | platelet-derived growth factor receptor |
- |
694492 |
| 2.7.10.2 | EPQYEEIPIYL |
a src kinase activating peptide, binds to the SH2 domain of the src-kinase and activates it, activation of endogenous src-PTKs does not inhibit Kv1.3 channels in T lymphocytes, overview |
675624 |
| 2.7.10.2 | more |
a treatment of leukemic bone marrow cells with a mixture of interleukin-2, interferon-gamma, and non-specific BRM sheep erythrocytes leads to an increase in enzyme activity |
661859 |
| 2.7.10.2 | more |
Abl-SH3 domain is implicated in negative regulation of the Abl kinase by mediating protein-protein interactions. High-affinity SH3 ligands can compete for these interactions and specifically activate the Abl kinase |
490058 |
